The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Synthetic Design Lab Inc., which emerged from stealth with a $20 million seed round and a platform technology aimed at advancing the antibody-drug conjugate (ADC) space, began with its founders ...

The latest tenant to graduate from the Portal Innovations incubator space in Chicago’s Fulton Market is now leasing 17,000 square feet at 400 North Aberdeen Street.

Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

A planned biosciences office and lab tower will remain unbuilt as Yale pulls back investments in light of possible federal ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

A developer that specializes in office to lab conversions secured the largest life science lease of 2025 in Boston with a ...